1. Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Adrien Rousseau et al, 2023, European Journal of Cancer CrossRef
  2. REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment
    Ehsan Ghorani et al, 2023, The Lancet Oncology CrossRef